Using aromatase inhibitors to stimulate a woman's ovaries
June 1st 2006Although clomiphene citrate and FSH remain the mainstay of therapy for ovarian stimulation among women with unexplained infertility, both drugs have their shortcomings. Two experts present the evidence supporting the value of AIs in this patient population.
Demystifying combined HPV-Pap screening guidelines, Part 2
June 1st 2006A leading expert helps you educate yourself-and your patients-about putting combined HPV-Pap testing into practice. Patient education should stress how common HPV is and explain the high level of reassurance testing negative on both tests affords.
Ovarian Ca risk assessment tool has potential
June 1st 2006Using a risk assessment score that incorporates CA 125 values, prealbumin, and menopausal status may help predict which women presenting with a pelvic mass are most likely to have ovarian cancer, according to this prize-winning paper presented at the 2006 ACOG clinical meeting in Washington, D.C.
Using liquid Pap tests to detect gonorrhea and chlamydia
June 1st 2006You can accurately test for Neisseria gonorrheae (NG) and Chlamydia trachomatis (CT) using the same liquid Pap specimens collected for cervical cytology, researchers from University of Oklahoma college of Medicine in Tulsa have concluded.
Less expensive screening for chromosomal abnormalities
June 1st 2006Reserving full karyotyping for the 10% of fetuses with first trimester nuchal translucency (NT) measurements of 4 mm or more and using quantitative fluorescent polymerase chain reaction (qf-PCR) for less suspicious samples may be an effective screening strategy that provides rapid results at significant cost savings, according to a recent observational study.
Statins reduce cholesterol, not risk of colorectal cancer
June 1st 2006Some studies have indicated that statins inhibit colorectal carcinogenesis in rodents. And one large case–control study from Israel-the Molecular Epidemiology of Colorectal Cancer (MECC) Trial-found that people who took statins for 5 years or more cut their risk of colorectal cancer in half.
Researchers find HPV vaccine safe, effective for 4.5 years
June 1st 2006Three immunizations with a bivalent human papillomavirus (HPV)-16/18 L1 virus-like particle AS04 vaccine safely induces sustained high levels of antibodies that provide long-term protection against HPV-16 and -18 infection and associated cervical lesions and possibly against HPV 45 and HPV 31-the third and fourth most common HPV types associated with cervical cancer-for up to 4.5 years.
Editorial: Prohibition didn't work, neither will an abortion ban
June 1st 2006The Supreme Court established a trimester-based paradigm to balance a woman's reproductive rights against the state's obligation to protect its unborn citizens. Were today's rhetoric taken to the extreme in a post-Roe world, we could see boycotts of a state's products, services, and tourism.